4.7 Article

Successful Treatment of a Patient With Severe COVID-19 Using an Integrated Approach Addressing Mast Cells and Their Mediators

Journal

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 118, Issue -, Pages 164-166

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2022.02.049

Keywords

Coronavirus; Fibrosis; Flavonoids; Inflammation; Lungs; Mast Cells; Treatment

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Neuroinflammation in Alzheimer's disease and beneficial action of luteolin

Alejandro Delgado, Christos Cholevas, Theoharis C. Theoharides

Summary: Alzheimer's disease, the most common form of dementia globally, is expected to continue to rise in prevalence in the coming decades. Despite historical research on the amyloid cascade hypothesis, recent literature emphasizes the key role of neuroinflammation, particularly microglial activation, in the pathogenesis of AD. In addition, flavonoids like luteolin in olive pomace oil combined with hydroxytyrosol show promise as a prophylactic treatment due to their beneficial effects.

BIOFACTORS (2021)

Review Biochemistry & Molecular Biology

Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue

Theoharis C. Theoharides, Christos Cholevas, Konstantinos Polyzoidis, Antonios Politis

Summary: COVID-19 not only causes severe respiratory problems but also leads to long-COVID syndrome, with symptoms including cognitive dysfunction and fatigue, particularly brain fog. The pathogenesis of brain fog in these illnesses is currently unknown, but may involve neuroinflammation caused by mast cells, which could be mitigated by the phytosomal formulation of the natural flavonoid luteolin.

BIOFACTORS (2021)

Review Health Care Sciences & Services

Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder

Theoharis C. Theoharides

Summary: The prevalence of autism spectrum disorder (ASD) is increasing, and while the exact pathogenesis and effective treatment remain unknown, research suggests that brain inflammation may play a significant role in neurodegenerative changes affecting emotions and fear regulation. Inflammation of the brain can be triggered by various factors, leading to disruptions in neuronal connectivity and emotional expression, as seen in ASD. Personalized treatment approaches targeting factors like mast cells and microglia activation may offer potential benefits for individuals with ASD.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Biochemistry & Molecular Biology

Meta-Analysis and Bioinformatics Detection of Susceptibility Genes in Diabetic Nephropathy

Maria Tziastoudi, Christos Cholevas, Theoharis C. Theoharides, Ioannis Stefanidis

Summary: This study utilized gene ontology analysis and protein network construction to identify the potential roles of immune-related molecules and Cadherin/Wnt signaling pathways in diabetic nephropathy, suggesting them as potential therapeutic targets for the treatment of DN.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?

Theoharis C. Theoharides

Summary: SARS-CoV-2 infects cells through its spike protein binding to the surface receptor, resulting in acute symptoms known as COVID-19. Increasing evidence suggests the development of a chronic condition called long-COVID, characterized by fatigue and neuropsychiatric symptoms. Studies have found that the spike protein may have neurotoxic effects, causing perivascular inflammation and neuro-inflammation, contributing to long-COVID symptoms.

MOLECULAR NEUROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19

Georgios Kassianidis, Athanasios Siampanos, Garyphalia Poulakou, George Adamis, Aggeliki Rapti, Haralampos Milionis, George N. Dalekos, Vasileios Petrakis, Styliani Sympardi, Symeon Metallidis, Zoi Alexiou, Theologia Gkavogianni, Evangelos J. Giamarellos-Bourboulis, Theoharis C. Theoharides

Summary: This study investigates the trajectory of moderate and severe COVID-19 progressing to ARDS requiring MV. The levels of various mediators were analyzed in patients at different stages of severity. The study found that levels of proinflammatory mediators were increased in patients with ARDS and MV, while levels of anti-inflammatory mediators also showed an increase. Pathways involving IL-6, IL-33, and calprotectin were significantly associated with worse outcomes. Further research is needed to understand the importance of these findings in relation to other acute-phase reactants.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Is there an interplay between the SARS-CoV-2 spike protein and Platelet-Activating factor?

Smaragdi Antonopoulou, Filio Petsini, Maria Detopoulou, Theoharis C. Theoharides, Constantinos A. Demopoulos

Summary: This study found that mRNA vaccination for COVID-19 affects human platelet aggregation response and the Spike protein modulates PAF production and activity. This finding may provide new directions for treating patients infected with SARS-CoV-2.

BIOFACTORS (2022)

Editorial Material Biochemistry & Molecular Biology

Platelet activating factor: Have we been missing the forest for the trees?

Theoharis C. Theoharides, Smaragdi Antonopoulou, Constantinos A. Demopoulos

BIOFACTORS (2022)

Review Immunology

Mast cell activation: beyond histamine and tryptase

Theoharis C. Theoharides, Adam I. Perlman, Assma Twahir, Duraisamy Kempuraj

Summary: Mast cells are involved in various disorders, including MCADs, and their activation mechanisms and released mediators can vary. Current emphasis on histamine and tryptase as mediators is insufficient to explain all the symptoms of MCADs, leading to a need for better detection and treatment methods.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Review Cell Biology

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID

Theoharis C. Theoharides, Duraisamy Kempuraj

Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, and approximately 45% of patients experience long-term fatigue and neurovascular inflammation. The spike protein of SARS-CoV-2 can disrupt the blood-brain barrier, damage neurons, and activate brain mast cells and microglia, resulting in the release of neuroinflammatory molecules. Recent evidence suggests that the flavanol eriodictyol, along with oleuropein and sulforaphane, may be effective in treating COVID-19 and its long-term consequences.

CELLS (2023)

Review Biochemistry & Molecular Biology

Potential Role of Moesin in Regulating Mast Cell Secretion

Theoharis C. Theoharides, Duraisamy Kempuraj

Summary: In addition to allergic reactions, mast cells can play a critical role in homeostasis and inflammation through secretion of various mediators. The molecular mechanisms regulating this secretion, particularly the involvement of ERM proteins, are not well understood. Phosphorylation of moesin was found to be associated with the inhibition of mast cell secretion, suggesting a potential role for moesin in regulating this process.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Biochemistry & Molecular Biology

The Role of Mast Cells and Their Inflammatory Mediators in Immunity

Theoharis C. Theoharides

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis

Maria Tziastoudi, Theoharis C. Theoharides, Evdokia Nikolaou, Maria Efthymiadi, Theodoros Eleftheriadis, Ioannis Stefanidis

Summary: This study aimed to identify the key factors of fibrosis in diabetic nephropathy. Through systematic review and meta-analysis, 16 genes were found to play a crucial role in driving the fibrosis process in diabetic nephropathy. However, caution should be exercised in interpreting the results due to the relatively small number of studies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

No Data Available